Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04355845 · ClinicalTrials.gov registry record · Phase 1
A Study TO Evaluate THE Effect OF PF-06651600 ON Pharmacokinetics OF Single Dose Sumatriptan IN Healthy Participants.
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04355845 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 10 participants.
The verdict
NCT04355845, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Study to evaluate the effect of pf-06651600 on pharmacokinetics of single dose sumatriptan.
Interventions
- DRUG PF-06651600
- DRUG Sumatriptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2020-08-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04355845
The ClinicalTrials.gov registry entry for NCT04355845 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PF-06651600 is the first listed.
NCT04355845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04355845 about?
NCT04355845 is a clinical study titled "A Study TO Evaluate THE Effect OF PF-06651600 ON Pharmacokinetics OF Single Dose Sumatriptan IN Healthy Participants.". Study to evaluate the effect of pf-06651600 on pharmacokinetics of single dose sumatriptan.
What is the current status of trial NCT04355845?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2020-06-15. Estimated completion is 2020-08-10.
What interventions are being tested in trial NCT04355845?
The interventions under investigation include: PF-06651600 (DRUG), Sumatriptan (DRUG).
Who is sponsoring clinical trial NCT04355845?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.